The Lancet Gastroenterology & Hepatology in conversation with
A podcast by The Lancet Group
88 Episoade
-
Acute hepatitis C
Publicat: 08.03.2019 -
Epidemiology of chronic liver disease
Publicat: 08.02.2019 -
Viral hepatitis in migrant populations
Publicat: 07.12.2018 -
DAA treatment for hepatitis C among people who inject drugs
Publicat: 25.10.2018 -
Pancreatic cancer treatment
Publicat: 06.09.2018 -
UDCA Response Score
Publicat: 10.08.2018 -
Global prevalence, treatment, and prevention of hepatitis B virus infection
Publicat: 03.05.2018 -
Neoplasia detection in ulcerative colitis
Publicat: 06.04.2018 -
Functional dyspepsia
Publicat: 08.03.2018 -
Can DAA therapy for HCV reactivate HBV in coinfected patients?
Publicat: 08.02.2018 -
Oral immunotherapy: The Lancet Gastroenterology & Hepatology: February 2018
Publicat: 13.01.2018 -
Faecal transplantation: The Lancet Gastroenterology & Hepatology: Jan 2018
Publicat: 09.12.2017 -
PROTECT study: The Lancet Gastroenterology & Hepatology: December 2017
Publicat: 09.11.2017 -
Research priorities in Barrett's and GORD: The Lancet Gastroenterology & Hepatology: August 31, 2017
Publicat: 02.09.2017 -
Neurostimulation for abdominal pain: The Lancet Gastroenterology & Hepatology: August 18, 2017
Publicat: 19.08.2017 -
Oesophageal motility and solid meal tests: The Lancet Gastroenterology & Hepatology: August 2, 2017
Publicat: 03.08.2017 -
HALT-HCC score: The Lancet Gastroenterology & Hepatology: July 5, 2017
Publicat: 06.07.2017 -
Early intervention for alcohol-related liver disease: The Lancet Gastroenterology and Hepatology: June 7, 2017
Publicat: 08.06.2017 -
Stem cell transplantation in Crohn's: The Lancet Gastroenterology & Hepatology: May 5, 2017
Publicat: 05.05.2017 -
Colorectal cancer in sub-Saharan Africa: The Lancet Gastroenterology & Hepatology: April 5, 2017
Publicat: 06.04.2017
Hugh Thomas, Deputy Editor at The Lancet Gastroenterology & Hepatology, in conversation with the journal’s authors, explores their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from predicting clinical outcomes in NAFLD to immunosuppressant withdrawal in patients with Crohn’s disease, the primary antibiotic resistance of Helicobacter pylori to surgical versus non-surgical management of malignant bowel obstruction, and more.
